By Chelsea Naso (April 15, 2014, 6:04 PM EDT) -- New York-based ConMed Corp., which has been battling it out with activist investors who have challenged the company's performance and corporate governance, has contacted large medical device companies to gauge their buyout interest as the surgical medical device maker considers a sale, Reuters reported Tuesday. ConMed, which has a market capitalization of roughly $1.2 billion, reportedly tapped its financial advisers Bank of America Merrill Lynch and Greenhill & Co. Inc. to reach out to potential buyers. Exploration of a potential sale comes as the company anticipates a tough proxy battle at its annual shareholder meeting expected to occur by the end of July with board nominations from Voce Capital Management LLC and Coppersmith Capital....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
